Navigation Links
PFCD Urges Congress to Address Real Cost-Driver in Health Reform in Light of New CBO Statement
Date:7/20/2009

CBO Announcement Says Current Legislation Does Not Include Cost-control Efforts, Costs Will Increase

WASHINGTON, July 20 /PRNewswire-USNewswire/ -- In response to a recent announcement by CBO Director Douglass Elmendorf about current legislative drafts proposed by the Senate and House, the PFCD urges Congress to address the number-one driver of health care costs in the U.S. -- chronic disease.

"The Senate HELP and House Ways and Means Committee drafts of the Affordable Health Choices Act include several critical reforms that will improve the quality of care delivered in our country, but do not adequately address rising health care costs nor provide the financial and structural means to sustain a reform of this magnitude," said Ken Thorpe, Ph.D., PFCD Executive Director. "We must focus on disease prevention and wellness in order to reduce unnecessary -- and often preventable -- costs and create a sustainable health care system."

The PFCD advocates for prevention and care coordination measures such as community health teams and transitional care models, to prevent and manage costly chronic disease.

"There is a growing body of evidence that prevention programs improve health outcomes and lead to better value per dollar invested in health care," said Thorpe. "To ignore this evidence would be detrimental to the health and economic stability of the country."

"We hope that as other Senate and House committees continue through mark ups, they will make certain that their bills contain adequate measures to address the economic burden of chronic disease and control costs in order to ensure the passage of comprehensive, sustainable health care reform legislation in 2009."

Chronic diseases, such as cancer, diabetes, and heart disease, account for 75 percent of every health care dollar spent in the U.S. The annual economic impact on the U.S. economy of the seven most common chronic diseases is calculated to be $1.3 trillion, which could balloon to nearly $6 trillion by the middle of the century. Chronic diseases are the number one cause of death and leading driver of rising health care costs in America. These are conditions that, with proper early intervention, diet, and exercise, could be prevented, delayed, or minimized. More than 130 million Americans today have a chronic disease.

About the Partnership to Fight Chronic Disease:

The Partnership to Fight Chronic Disease (PFCD) is a national and state-based coalition of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: chronic disease. For more information about the PFCD and its partner organizations, please visit: www.fightchronicdisease.org.


'/>"/>
SOURCE Partnership to Fight Chronic Disease
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
3. National Council on Disability Urges Congress to Support Americans with Disabilities Act Restoration
4. Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year
5. SHRM Testimony Urges Congress to Fix FMLA
6. AMA Urges Congress to Stop Medicare Cuts
7. APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto
8. Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill
9. APHA Urges President Bush Not To Veto CHIP; Were Only One Signature Away from Protecting the Health of Our Children
10. Health Secretary Urges Pennsylvanians to Get a Flu Shot
11. American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/26/2017)... ... 2017 , ... ODH, Inc.™ announced today it will exhibit and speak ... City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will ... Medicaid population health management. , ODH will also have an exhibit booth where attendees ...
(Date:2/26/2017)... ... 2017 , ... Occupational pesticide exposure is linked to an ... according to a study released today at the 1st Pan American Parkinson’s and ... pesticides and incidence of sporadic PD through occupational exposure. This latest study, led ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... ... two months after the official release of The Private Collection – Edition 2017 at ... a second print-run of its lavish luxury travel coffee table book. , An ... at more than six kilos, retails at EUR 1,000 per copy and is packed ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology: